---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-009698"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T01:33:20.015945+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# PAVmed subsidiary Lucid Diagnostics closes ~$15.3M equity offering at $1.10/share

## Summary
- Lucid Diagnostics sold 13.9M shares at $1.10 each, gross proceeds ~$15.3M.
- Net proceeds estimated ~$14.5M after placement agent fees and expenses.
- Proceeds expected to be used for working capital and general corporate purposes.
- Offering closed on March 5, 2025, pursuant to an existing shelf registration statement.

## SEC filing metadata
- accession: 0001493152-25-009698
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315225009698/0001493152-25-009698-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315225009698/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-009698
- JSON: https://secwatch.observer/filing/0001493152-25-009698.json
- Plain text: https://secwatch.observer/filing/0001493152-25-009698.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.